CIK: 0001737053
Total reported value
$38.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Apellis Pharmaceuticals, Inc | Stock-Other | 48.78% | +6.34% | — | |
| 2 | MNLOUSD | Menlo Therapeutics INC | Stock-Other | 33.85% | -9.36% | — | |
| 3 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 10.79% | +3.03% | — | |
| 4 | ✓ | Nabriva Therapeutics PLC | Stock-Other | 6.58% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VRNA | Verona Pharma PLC - Adr | +0.5% | — | Unchanged |
| 2 | ✓ | Nabriva Therapeutics PLC | -6% | — | Unchanged |
| 3 | ✓ | Apellis Pharmaceuticals, Inc | -28.3% | — | Unchanged |
| 4 | MNLOUSD | Menlo Therapeutics INC | — | NEW | New buy |